• Recent DDS platforms significantly improve tumor targeting and reduce off-target effects.
• Stimuli-responsive release mechanisms enable precise spatiotemporal control of drug delivery.
• Combination therapies using DDS show synergistic effects and overcome multidrug resistance.
• Clinical translation remains challenging due to tumor heterogeneity and scale-up issues.